Liver study on cancer drug halted after just 2 patients
NCT ID NCT05209295
First seen Jan 12, 2026 · Last updated Jun 16, 2026 · Updated 22 times
Summary
This study aimed to see how moderate or severe liver problems change the way the body handles the blood cancer drug oral azacitidine (Onureg). It planned to compare drug levels in people with and without liver issues. However, the study was stopped early after only 2 participants enrolled, so no clear conclusions could be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution
Cleveland, Ohio, 44106, United States
-
Local Institution - 0010
ABB, Buenos Aires F.D., C1199ABB, Argentina
-
Local Institution - 0011
Pilar, Buenos Aires, 1629, Argentina
-
Local Institution - 0012
Buenos Aires, 1426, Argentina
-
Local Institution - 0014
Buenos Aires, Buenos Aires F.D., C1118AAT, Argentina
-
Local Institution - 0015
Pamplona, Navarre, 31008, Spain
-
Local Institution - 0017
Barcelona, Barcelona [Barcelona], 08035, Spain
-
Local Institution - 0018
Badalona, Barcelona [Barcelona], 08916, Spain
-
Local Institution - 0069
Detroit, Michigan, 48202, United States
-
Local Institution - 0074
Hamburg, 20246, Germany
-
Local Institution - 0075
Halle, Saxony-Anhalt, 06120, Germany
-
Local Institution - 0076
Augsburg, Bavaria, 86156, Germany
-
Local Institution - 0078
Salamanca, 37007, Spain
-
Local Institution - 0083
Iowa City, Iowa, 52242, United States
-
Local Institution - 0084
Bogota, Cundinamarca, 111151, Colombia
-
Local Institution - 0085
Bogotá, Bogota D.C., 110131, Colombia
-
Local Institution - 0086
Piedecuesta, Santander Department, 681017, Colombia
-
Local Institution - 9003
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.